Compare Procter & Gamble Health with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH DR. REDDYS LAB PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
 
P/E (TTM) x 36.4 34.0 107.1% View Chart
P/BV x 9.6 4.1 235.1% View Chart
Dividend Yield % 3.2 0.6 552.0%  

Financials

 PROCTER & GAMBLE HEALTH   DR. REDDYS LAB
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-21
DR. REDDYS LAB
Mar-21
PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs7,5005,515 136.0%   
Low Rs4,0043,028 132.2%   
Sales per share (Unadj.) Rs607.71,145.4 53.1%  
Earnings per share (Unadj.) Rs106.5114.5 93.0%  
Cash flow per share (Unadj.) Rs124.6188.4 66.2%  
Dividends per share (Unadj.) Rs130.0025.00 520.0%  
Avg Dividend yield %2.30.6 386.1%  
Book value per share (Unadj.) Rs421.61,053.2 40.0%  
Shares outstanding (eoy) m16.60166.30 10.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.53.7 253.8%   
Avg P/E ratio x54.037.3 144.7%  
P/CF ratio (eoy) x46.222.7 203.6%  
Price / Book Value ratio x13.64.1 336.4%  
Dividend payout %122.121.8 558.8%   
Avg Mkt Cap Rs m95,477710,289 13.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,50536,299 4.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,087190,475 5.3%  
Other income Rs m1812,914 6.2%   
Total revenues Rs m10,268193,389 5.3%   
Gross profit Rs m2,46038,699 6.4%  
Depreciation Rs m30012,288 2.4%   
Interest Rs m8970 0.8%   
Profit before tax Rs m2,33328,355 8.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5659,319 6.1%   
Profit after tax Rs m1,76819,036 9.3%  
Gross profit margin %24.420.3 120.0%  
Effective tax rate %24.232.9 73.7%   
Net profit margin %17.510.0 175.4%  
BALANCE SHEET DATA
Current assets Rs m10,389145,503 7.1%   
Current liabilities Rs m5,50781,038 6.8%   
Net working cap to sales %48.433.8 143.0%  
Current ratio x1.91.8 105.1%  
Inventory Days Days28961 471.2%  
Debtors Days Days21595 226.1%  
Net fixed assets Rs m9,390109,979 8.5%   
Share capital Rs m166832 20.0%   
"Free" reserves Rs m6,832174,319 3.9%   
Net worth Rs m6,998175,151 4.0%   
Long term debt Rs m06,299 0.0%   
Total assets Rs m19,778255,482 7.7%  
Interest coverage x292.630.2 967.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.7 68.4%   
Return on assets %9.07.8 114.7%  
Return on equity %25.310.9 232.4%  
Return on capital %33.416.2 207.0%  
Exports to sales %051.3 0.0%   
Imports to sales %14.518.1 80.2%   
Exports (fob) Rs mNA97,699 0.0%   
Imports (cif) Rs m1,46234,420 4.2%   
Fx inflow Rs m1,33197,699 1.4%   
Fx outflow Rs m1,46234,420 4.2%   
Net fx Rs m-13163,279 -0.2%   
CASH FLOW
From Operations Rs m2,47335,703 6.9%  
From Investments Rs m-323-22,660 1.4%  
From Financial Activity Rs m-3,866-298 1,297.4%  
Net Cashflow Rs m-1,71612,858 -13.3%  

Share Holding

Indian Promoters % 0.0 26.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 14.5 49.9 29.0%  
FIIs % 6.6 25.2 26.1%  
ADR/GDR % 0.0 11.2 -  
Free float % 48.2 62.1 77.6%  
Shareholders   66,289 263,803 25.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    CIPLA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    

Yellow Ad

Advertisement

A One Stock Gift in 1990 Turns into Rs 130 Crores

In 2017, Ravi made headlines by calling a leading business news channel with a surprising announcement - his grandfather had left him 20,000 shares of only one stock.

And on the day of his call - these shares were worth Rs 130 crore.

Can you guess which is this company?

It's MRF.

Ravi's story is one of the amazing stories of becoming Crorepati from a single stock.

But the question is, how to find that one stock with crorepati potential?

To find the answer to this million-dollar question, join our 'One Stock Crorepati' MEGA summit on 30th June, where we will reveal details of what we call a potential 'crorepati' stock...

Learn more



Today's Market

Sensex Zooms 462 Points, Nifty Ends Near 15,700; Auto & FMCG Stocks Rally(Closing)

Indian share markets ended the week on a firm note tracking positive global cues.

Related Views on News

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jun 24, 2022 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - DESH RAKSHAK COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS